Showing 1 - 3 results of 3 for search 'Jill Fiedler-Kelly', query time: 0.02s Refine Results
  1. 1
    Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study

    Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study by Aksana Jones, Orit Cohen-Barak, Andrijana Radivojevic, Jill Fiedler-Kelly

    Published 2021-05-01
    Get full text
    Article
  2. 2
    A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis.

    A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis. by Himanshu Naik, Max C Tsai, Jill Fiedler-Kelly, Ping Qiu, Majid Vakilynejad

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections

    Efficacy, safety, tolerability and population pharmacokinetics of tedizolid, a novel antibiotic, in Latino patients with acute bacterial skin and skin structure infections by Alejandro Ortiz-Covarrubias, Edward Fang, Philippe G. Prokocimer, Shawn D. Flanagan, Xu Zhu, Jose Francisco Cabré-Márquez, Toshiaki Tanaka, Julie Passarell, Jill Fiedler-Kelly, Esteban C. Nannini

    Published 2016-03-01
    Get full text
    Article

Search Tools: